"10.1371_journal.pone.0070150","plos one","2013-08-01T00:00:00Z","Tova Neufeld; Barbara Ludwig; Uriel Barkai; Gordon C Weir; Clark K Colton; Yoav Evron; Maria Balyura; Karina Yavriyants; Baruch Zimermann; Dmitri Azarov; Shiri Maimon; Noa Shabtay; Tania Rozenshtein; Dana Lorber; Anja Steffen; Udi Willenz; Konstantine Bloch; Pnina Vardi; Ran Taube; Paul de Vos; Eli C Lewis; Stefan R Bornstein; Avi Rotem","Technology Department, Beta-O2 Technologies, Rosh HaAyin, Israel; Department of Medicine III, University Hospital Carl Gustav Carus, Dresden, Germany; Islet Department, Beta-O2 Technologies, Rosh HaAyin, Israel; Section of Islet Trasnplantation and Cell Biology, Joslin Diabetes Center, Boston, Massachusetts, United States of America; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America; Veterinary Department, Lahav Research Institute, Lahav, Israel; Diabetes and Obesity Research Laboratory, Faculty of Medicine - Tel Aviv University (Beilinson Campus), Petah Tikva, Israel; Department of Microbiology Immunology and Genetics, Ben-Gurion University of the Negev, Beer-Sheva, Israel; Department of Pathology and Laboratory Medicine, University Medical Center Groningen, Groningen, The Netherlands; Department of Clinical Biochemistry and Pharmacology, Ben-Gurion University of the Negev, Beer-Sheva, Israel","Â¶ These authors also contributed equally to this work.","TN, UB, YE, DA, KY, BZ, SM, NS, TR, IM, YR, ZS, DL, TG, NS, MB and AR are employees of Beta-O2. GW, PV, KB and CC are stock option holders in Beta-O2. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","08","Tova Neufeld","TN",23,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
